Medical News

RSS

BIND Therapeutics reports revenue of $2.1 million for fourth quarter 2013

BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today reported financial results for the fourth quarter and year-ended December 31, 2013.

25 Mar 2014

PatientPoint signs distribution agreement with HealthTronics IT Solutions for urology technology

PatientPoint announced today that they have entered into a distribution agreement with HealthTronics IT Solutions to deliver population health management solutions within urology to drive improved adherence and compliance.

25 Mar 2014

Communispace launches new business unit for health care companies

Communispace – the leading consumer collaboration agency – today announced the launch of Communispace Health, a new business unit dedicated to helping health care companies collaborate with consumers to create greater impact and develop competitive advantage in the marketplace. Communispace Vice President, Corey Schwartz, has been named Managing Director of Communispace Health.

25 Mar 2014

TriMed Technologies' EHR version 7.9 achieves 2014 Edition Complete Ambulatory EHR Certification

TriMed Technologies, a leading provider of physician based healthcare information solutions, announced that its EHR (Electronic Health Record) version 7.9, has received 2014 Edition Complete Ambulatory EHR Certification, which designates that the software is capable of supporting healthcare providers with Stage 1 and Stage 2 Meaningful Use measures required to qualify for funding under the American Recovery and Reinvestment Act (ARRA).

25 Mar 2014

Precision for Medicine announces acquisition of Hobart Group Holdings

Precision for Medicine, Inc., formed in 2012 to support next generation approaches to drug development and commercialization, announces the acquisition of Hobart Group Holdings, LLC, a leading market access firm. With this addition, Precision for Medicine has established the foundation for its next phase of growth in providing integrated solutions focused on demonstrating value in the era of precision medicine.

25 Mar 2014

First Edition: March 25, 2014

Today's early morning highlights from the major news organizations, including stories previewing today's Supreme Court action regarding the health law's contraception coverage mandate.

25 Mar 2014

Endogenous tissue growth: an interview with Laurent Grandidier, CEO, Xeltis

ETG or Endogenous Tissue Growth is a new therapeutic category in which surgeons use implants designed to allow the body to repair itself by spontaneously growing natural, healthy tissue from the inside without the use of stem cells or animal-derived products.

25 Mar 2014

European Commission approves Exelixis' COMETRIQ for treatment of progressive, metastatic MTC

Exelixis, Inc. today announced that the European Commission has approved COMETRIQ (cabozantinib) for the treatment of adult patients with progressive, unresectable locally advanced or metastatic medullary thyroid carcinoma (MTC).

25 Mar 2014

Genable Technologies, Spark Therapeutics to advance novel therapy for rare form of retinitis pigmentosa

Spark Therapeutics and Genable Technologies announced today that they have entered into a collaboration agreement for Genable's lead therapeutic to treat rhodopsin-linked autosomal dominant retinitis pigmentosa (RHO adRP), GT038.

25 Mar 2014

Autism Society celebrates National Autism Awareness Month in April 2014

The Autism Society, the nation's leading grassroots autism organization, celebrates National Autism Awareness Month in April 2014. Focusing on the people, groups and policies that make "A Better World for Autism,", the Autism Society and over 100 affiliate organizations nationwide, along with the American autism community will shed light on a developmental disability that affects over 1.5 million people in the United States.

25 Mar 2014

Visivite launches gentle macular health formula, AREDS2 Silver

VisiVite®, a world leader in eye vitamins, today announced its launch of a gentle new macular health formula: AREDS2 Silver®. Based on the National Eye Institute's Age-Related Eye Disease Studies (AREDS and AREDS2), AREDS2 Silver supplies antioxidants for macular health without the high levels of zinc that may cause issues in those with zinc sensitivities and allergies.

25 Mar 2014

The Center for Applied Nanotechnology presents a ready-to-use reagent for the detection of poly-histidine tagged proteins in Blot assays

The nano-experts from the Center for Applied Nanotechnology (CAN) GmbH expand their product portfolio by CANdots® Series G - His Detect, which is a ready-to-use reagent for the detection of poly-histidine tagged proteins in Blot assays. It is easy to handle, highly sensitive as well as time saving compared to standard methods available on the market, e.g. ECL.

25 Mar 2014

Vestibular system is critical for optimizing head and eye movements

Neurologists at Ludwig-Maximilians-Universitaet (LMU) in Munich have studied the role of the vestibular system, which controls balance, in optimizing how we direct our gaze. The results could lead to more effective rehabilitation of patients with vestibular or cerebellar dysfunction.

25 Mar 2014

Viewpoints: Mcconnell, Wasserman Schultz, Barasso on Obamacare's 4th anniversary; defending surgeon general nominee

The promises that were made to sell Obamacare - that it wouldn't disrupt people's previous health care arrangements and that premiums would go down - are now being exposed for the cheap and deceptive sales pitch they were. It may be tempting for some to brush all this aside as standard politics.

25 Mar 2014

Radiation therapy fights cancer in more ways than one

Radiation therapy fights cancer in more ways than one. Not only does it force cancer cells to self-destruct, but several studies demonstrate that it also activates the immune system to attack tumor cells.

25 Mar 2014

Researchers receive grants to advance work in prevention of premature birth

Researchers at UT Southwestern Medical Center received grants totaling $600,000 from the March of Dimes Foundation to advance their work in the prevention of premature birth, which affects about one out of nine babies born annually in the U.S. and is the leading cause of newborn death.

25 Mar 2014

Study examines enrollment, use, and satisfaction with fee-for-service multispecialty system

Many physicians are adopting patient portals in response to governmental incentives for meaningful use (MU), but the stage 2 requirements for portal use may be particularly challenging for newer electronic health record (EHR) users.

25 Mar 2014

Researchers develop mathematical model that provides insights about molecular mechanisms behind virus assembly

Mathematicians at the University of York have joined forces with experimentalists at the University of Leeds to take an important step in discovering how viruses make new copies of themselves during an infection.

25 Mar 2014

Researchers discover novel population of neutrophils that exhibit enhanced microbial killing activity

Case Western Reserve University researchers have discovered a novel population of neutrophils, which are the body's infection control workhorses. These cells have an enhanced microbial killing ability and are thereby better able to control infection.

25 Mar 2014

ISTH declares Oct.13 as World Thrombosis Day

Bringing together nations and local communities to tackle thrombosis, the quiet, underlying disorder that is the common mechanism of the world's three top cardiovascular killers – heart attack, stroke and venous thromboembolism (VTE) – the International Society on Thrombosis and Haemostasis (ISTH) today announced that October 13 will be designated World Thrombosis Day, with the inaugural event to be held this year.

25 Mar 2014

Medical News

BIND Therapeutics reports revenue of $2.1 million for fourth quarter 2013

PatientPoint signs distribution agreement with HealthTronics IT Solutions for urology technology

Communispace launches new business unit for health care companies

TriMed Technologies' EHR version 7.9 achieves 2014 Edition Complete Ambulatory EHR Certification

Precision for Medicine announces acquisition of Hobart Group Holdings

First Edition: March 25, 2014

Endogenous tissue growth: an interview with Laurent Grandidier, CEO, Xeltis

European Commission approves Exelixis' COMETRIQ for treatment of progressive, metastatic MTC

Genable Technologies, Spark Therapeutics to advance novel therapy for rare form of retinitis pigmentosa

Autism Society celebrates National Autism Awareness Month in April 2014

Visivite launches gentle macular health formula, AREDS2 Silver

The Center for Applied Nanotechnology presents a ready-to-use reagent for the detection of poly-histidine tagged proteins in Blot assays

Vestibular system is critical for optimizing head and eye movements

Viewpoints: Mcconnell, Wasserman Schultz, Barasso on Obamacare's 4th anniversary; defending surgeon general nominee

Radiation therapy fights cancer in more ways than one

Researchers receive grants to advance work in prevention of premature birth

Study examines enrollment, use, and satisfaction with fee-for-service multispecialty system

Researchers develop mathematical model that provides insights about molecular mechanisms behind virus assembly

Researchers discover novel population of neutrophils that exhibit enhanced microbial killing activity

ISTH declares Oct.13 as World Thrombosis Day

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Latest News